IRIS Accounts Production v25.4.0.155 06844311 director 28.3.24 27.3.25 27.3.25 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh068443112024-03-27068443112025-03-27068443112024-03-282025-03-27068443112023-03-27068443112023-03-282024-03-27068443112024-03-2706844311ns14:PoundSterling2024-03-282025-03-2706844311ns10:Director12024-03-282025-03-2706844311ns10:PrivateLimitedCompanyLtd2024-03-282025-03-2706844311ns10:SmallEntities2024-03-282025-03-2706844311ns10:AuditExemptWithAccountantsReport2024-03-282025-03-2706844311ns10:SmallCompaniesRegimeForDirectorsReport2024-03-282025-03-2706844311ns10:SmallCompaniesRegimeForAccounts2024-03-282025-03-2706844311ns10:FullAccounts2024-03-282025-03-270684431112024-03-282025-03-2706844311ns10:RegisteredOffice2024-03-282025-03-2706844311ns5:CurrentFinancialInstruments2025-03-2706844311ns5:CurrentFinancialInstruments2024-03-2706844311ns5:Non-currentFinancialInstruments2025-03-2706844311ns5:Non-currentFinancialInstruments2024-03-2706844311ns5:ShareCapital2025-03-2706844311ns5:ShareCapital2024-03-2706844311ns5:RetainedEarningsAccumulatedLosses2025-03-2706844311ns5:RetainedEarningsAccumulatedLosses2024-03-2706844311ns5:IntangibleAssetsOtherThanGoodwill2024-03-282025-03-2706844311ns5:LeaseholdImprovements2024-03-282025-03-2706844311ns5:PlantMachinery2024-03-282025-03-2706844311ns5:FurnitureFittings2024-03-282025-03-2706844311ns5:MotorVehicles2024-03-282025-03-2706844311ns5:NetGoodwill2024-03-2706844311ns5:NetGoodwill2025-03-2706844311ns5:NetGoodwill2024-03-2706844311ns5:LeaseholdImprovements2024-03-2706844311ns5:PlantMachinery2024-03-2706844311ns5:FurnitureFittings2024-03-2706844311ns5:MotorVehicles2024-03-2706844311ns5:LeaseholdImprovements2025-03-2706844311ns5:PlantMachinery2025-03-2706844311ns5:FurnitureFittings2025-03-2706844311ns5:MotorVehicles2025-03-2706844311ns5:LeaseholdImprovements2024-03-2706844311ns5:PlantMachinery2024-03-2706844311ns5:FurnitureFittings2024-03-2706844311ns5:MotorVehicles2024-03-2706844311ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-2706844311ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-2706844311ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2025-03-2706844311ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2024-03-27068443111ns10:Director12024-03-27068443111ns10:Director12023-03-27068443111ns10:Director12024-03-282025-03-27068443111ns10:Director12023-03-282024-03-27068443111ns10:Director12025-03-27068443111ns10:Director12024-03-27
REGISTERED NUMBER: 06844311











REPORT OF THE DIRECTOR AND

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 27 MARCH 2025

FOR

BRIGHTON IMPLANT CLINIC LTD

BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 27 MARCH 2025










Page

Company Information 1

Report of the Director 2

Income Statement 3

Balance Sheet 4

Notes to the Financial Statements 6


BRIGHTON IMPLANT CLINIC LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 27 MARCH 2025







DIRECTOR: B M Pedra Silva





REGISTERED OFFICE: 12 Church Road
Hove
East Sussex
BN3 2FL





REGISTERED NUMBER: 06844311





ACCOUNTANTS: Galloways Accounting (Hove) Limited
15 West Street
Brighton
East Sussex
BN1 2RL

BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

REPORT OF THE DIRECTOR
FOR THE YEAR ENDED 27 MARCH 2025


The director presents his report with the financial statements of the company for the year ended 27 March 2025.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of cosmetic dentistry.

DIRECTOR
B M Pedra Silva held office during the whole of the period from 28 March 2024 to the date of this report.

POLITICAL DONATIONS AND EXPENDITURE
During the year the company paid £200 per month to Hangelton & West Blatchington Food Bank.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





B M Pedra Silva - Director


27 December 2025

BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

INCOME STATEMENT
FOR THE YEAR ENDED 27 MARCH 2025

2025 2024
Notes £    £   

TURNOVER 6,733,896 6,301,982

Cost of sales (4,985,603 ) (4,748,193 )
GROSS PROFIT 1,748,293 1,553,789

Administrative expenses (1,067,291 ) (1,003,588 )
681,002 550,201

Other operating income - 10,913
OPERATING PROFIT 681,002 561,114

Interest receivable and similar income 15,538 10,856
696,540 571,970

Interest payable and similar expenses (64,788 ) (107,048 )
PROFIT BEFORE TAXATION 631,752 464,922

Tax on profit (133,112 ) (2,138 )
PROFIT FOR THE FINANCIAL YEAR 498,640 462,784

BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

BALANCE SHEET
27 MARCH 2025

2025 2024
Notes £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 653,588 633,120
653,588 633,120

CURRENT ASSETS
Stocks 40,000 40,000
Debtors 6 1,746,281 1,368,960
Cash at bank and in hand 89,833 31,150
1,876,114 1,440,110
CREDITORS
Amounts falling due within one year 7 (1,200,666 ) (1,092,216 )
NET CURRENT ASSETS 675,448 347,894
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,329,036

981,014

CREDITORS
Amounts falling due after more than one
year

8

(537,905

)

(653,965

)
NET ASSETS 791,131 327,049

CAPITAL AND RESERVES
Called up share capital 2 2
Retained earnings 791,129 327,047
SHAREHOLDERS' FUNDS 791,131 327,049

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 27 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 27 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

BALANCE SHEET - continued
27 MARCH 2025


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 27 December 2025 and were signed by:





B M Pedra Silva - Director


BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 27 MARCH 2025


1. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

This is the first year in which the financial statements have been prepared under FRS 102. Any changes in accounting policy have been applied from the first day of the previous period. Equity has been reconciled to the previously stated amounts for the opening and closing position of the comparative period.

Turnover
Turnover represents sales of services and is recognised at the point the customer is entitled to consideration.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Improvements to property - 7% on cost
Plant and machinery - 25% on reducing balance
Fixtures and fittings - 25% on cost
Motor vehicles - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

2. EMPLOYEES

The average number of employees during the year was 43 (2024 - 48 ) .

3. EXCEPTIONAL ITEMS
2025 2024
£    £   
Agua Vida Loan write off (43,189 ) -

BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 27 MARCH 2025


4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 28 March 2024
and 27 March 2025 3,700,000
AMORTISATION
At 28 March 2024
and 27 March 2025 3,700,000
NET BOOK VALUE
At 27 March 2025 -
At 27 March 2024 -

5. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and Motor
property machinery fittings vehicles Totals
£    £    £    £    £   
COST
At 28 March 2024 1,114,877 1,082,338 21,478 58,842 2,277,535
Additions - 191,171 995 - 192,166
At 27 March 2025 1,114,877 1,273,509 22,473 58,842 2,469,701
DEPRECIATION
At 28 March 2024 745,263 857,534 3,293 38,325 1,644,415
Charge for year 78,048 82,998 5,523 5,129 171,698
At 27 March 2025 823,311 940,532 8,816 43,454 1,816,113
NET BOOK VALUE
At 27 March 2025 291,566 332,977 13,657 15,388 653,588
At 27 March 2024 369,614 224,804 18,185 20,517 633,120

6. DEBTORS
2025 2024
£    £   
Amounts falling due within one year:
Trade debtors 266,413 129,094
Amounts owed by group undertakings 1,176 -
Other debtors 24,788 29,916
Tax 184,366 180,831
Prepayments and accrued income 105,162 104,590
581,905 444,431

BRIGHTON IMPLANT CLINIC LTD (REGISTERED NUMBER: 06844311)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 27 MARCH 2025


6. DEBTORS - continued
2025 2024
£    £   
Amounts falling due after more than one year:
Directors' loan accounts 1,164,376 924,529

Aggregate amounts 1,746,281 1,368,960

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 190,545 253,246
Hire purchase contracts 46,958 33,921
Trade creditors 633,828 573,289
Tax 136,646 52,948
Social security and other taxes 16,180 20,405
Other creditors 148,778 147,763
Accrued expenses 27,731 10,644
1,200,666 1,092,216

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Bank loans - 1-5 years 424,277 607,346
Hire purchase contracts 113,628 46,619
537,905 653,965

9. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 27 March 2025 and 27 March 2024:

2025 2024
£    £   
B M Pedra Silva
Balance outstanding at start of year 924,529 809,348
Amounts advanced 586,142 396,339
Amounts repaid (346,294 ) (281,158 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 1,164,377 924,529

This balance represented the maximum amount outstanding during the year. Interest is charged on any overdrawn amounts at the beneficial loan interest rate.

10. ULTIMATE CONTROLLING PARTY

The company's ultimate controlling parties are Mr B M Silva and Mrs M A J Silva by virtue of their combined 100% shareholding in the company.